Periocular syringomas – Successful treatment with fractional CO2 laser

  • Alberto Goldman Clinica Goldman, Porto Alegre, RS, Brazil
  • Uwe Wollina Department of Dermatology and Allergology Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany
Keywords: syringoma, treatment, esthetics, fractional CO2 laser

Abstract

Syringoma is a benign tumor of eccrine origin which arises from eccrine ducts. Syringomas are most commonly found on the eyelids in middle-aged women. Traditional treatments include surgical excision, curettage, peelings, dermabrasion and laser. We report on the successful use of fractional laser on periocular syringomas. A 53-year-old female patient with multiple periorbital syringomas underwent three sessions of fractional carbon dioxide (CO2) laser. Settings of 20 watts of power, 600 μm of spacing, 800 μs of dwell, time stack 2 (Smartxide DOT, DEKA, Florence, Italy) were used. The sessions were performed monthly. Significant improvement of the esthetic appearance was observed after three sessions. There was a decrease of visible syringomas associated with an evident improvement of the skin texture, skin quality and flaccidity. No side effects were observed. We suggested continuing the treatment but the patient was satisfied with the current aspect and result. In conclusion, fractional CO2 laser represents an effective treatment option for the treatment of periorbital syringomas.

Author Biographies

Alberto Goldman, Clinica Goldman, Porto Alegre, RS, Brazil
Director of Clinica Goldman
Uwe Wollina, Department of Dermatology and Allergology Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany
Head of department

References

Lee JH, Chang JY, Lee KH. Syringoma: A clinicopathologic and immunohistologic study and results of treatment. Yonsei Med J 2007; 48(1): 35–40. doi: 10.3349/ymj.2007.48.1.35.

Ghanadan A, Khosravi M. Cutaneous syringoma: A clinicopathologic study of 34 new cases and review of the literature. Indian J Dermatol 2013; 58(4): 326. doi: 10.4103/0019-5154.113956.

Turan E, Yurt N, Yeşilova Y, Tanrıkulu O. A rare association in Down syndrome: Milialike idiopathic calcinosis cutis and palpebral syringoma. Cutis 2016; 98(6): E22–E23.

Incel Uysal P, Yalcin B, Ozhamam E, Bozdogan O. Co-existence of adult onset eruptive syringoma and bilateral renal cell carcinoma: A case report. Am J Dermatopathol 2017; 39(1): 56–58. doi: 10.1097/DAD.0000000000000592.

Kavala M, Can B, Zindanci I, Kocatürk E, Türkoğlu Z, et al. Vulvar pruritus caused by syringoma of the vulva. Int J Dermatol 2008; 47(8): 831–832. doi: 10.1111/j.1365-4632.2008.03664.x.

Wollina U, Schaarschmidt H, Rülke D. Sweat gland tumors of skin—Immunohistochemistry with common antibodies in the paraffin section. Int J Oncol 1992; 1(4): 395–402. doi: 10.3892/ijo.1.4.395.

Kim BC, Park EJ, Kwon IH, Cho HJ, Park HR, et al. An immunohistochemical study of the origin of the solid strand in syringoma, using carcinoembryonic antigen, epithelial membrane antigen, and cytokeratin 5. Int J Dermatol 2012; 51(7): 817–822. doi: 10.1111/j.1365-4632.2011.05069.x.

Wollina U. Erbium-YAG laser therapy—Analysis of more than 1,200 treatments. J Glob Dermatol 2016; 3(2): 268–272. doi: 10.15761/GOD.1000171.

Hunzeker CM, Weiss ET, Geronemus RG. Fractionated CO2 laser resurfacing: Our experience with more than 2000 treatments. Aesthet Surg J 2009; 29(4): 317–322. doi: 10.1016/j.asj.2009.05.004.

Grunewald S, Bodendorf M, Illes M, Kendler M, Simon JC, et al. In vivo wound healing and dermal matrix re-modelling in response to fractional CO2 laser intervention: Clinicopathological correlation in non-facial skin. Int J Hyperthermia 2011; 27(8): 811–818. doi: 10.3109/02656736.2011.595380.

Skovbølling Haak C, Illes M, Paasch U, Hædersdal M. Histological evaluation of vertical laser channels from ablative fractional resurfacing: An ex vivo pig skin model. Lasers Med Sci 2011; 26(4): 465–471. doi: 10.1007/s10103-010-0829-2.

Tierney EP, Hanke CW, Petersen J. Ablative fractionated CO2 laser treatment of photoaging: A clinical and histologic study. Dermatol Surg 2012; 38(11): 1777–1789. doi: 10.1111/j.1524-4725.2012.02572.x.

Kitano Y. Erbium YAG laser treatment of periorbital syringomas by using the multiple ovoid-shape ablation method. J Cosmet Laser Ther 2016; 18(5): 280–285. doi: 10.3109/14764172.2016.1157361.

Seo HM, Choi JY, Min J, Kim WS. Carbon dioxide laser combined with botulinum toxin A for patients with periorbital syringomas. J Cosmet Laser Ther 2016; 18(3): 149–153. doi: 10.3109/14764172.2015.1052517.

Lee SJ, Goo B, Choi MJ, Oh SH, Chung WS, et al. Treatment of periorbital syringoma by the pinhole method using a carbon dioxide laser in 29 Asian patients. J Cosmet Laser Ther 2015; 17(5): 273–276. doi: 10.3109/14764172.2015.1027224.

Cho SB, Kim HJ, Noh S, Lee SJ, Kim YK, et al. Treatment of syringoma using an ablative 10,600-nm carbon dioxide fractional laser: A prospective analysis of 35 patients. Dermatol Surg 2011; 37(4): 433–438. doi: 10.1111/j.1524-4725.2011.01915.x.

Published
2021-06-04
Section
Case Reports